跳至主要内容
临床试验/ISRCTN66219681
ISRCTN66219681已完成未知

A randomised trial comparing delivery of cancer systemic therapy in three different settings: patient's home, outreach surgery and hospital day unit

Cambridge University Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 97 人开始时间: 2010年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
97

研究概览

简要总结

2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23989945 results

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •1. Any cancer patient being treated at either Cambridge University Hospital (CUH) or West Suffolk Hospital (WSH)
  • •2. Prepared to be considered for treatment at home or at one of the three defined outreach surgeries as alternatives to standard hospital treatment
  • •3. Life expectancy greater than 6 months
  • •4. Either commencing a course of treatment planned to last a minimum of 3 months, or having already commenced a course of treatment which is planned to continue for a minimum of 3 further months
  • •5. Course of treatment may be aimed at cure, palliation or supportive care
  • •6. Has hot and cold running water
  • •7. Has an indoor toilet
  • •8. Has a working telephone
  • •9. Is not dependant on hospital transport
  • •10. Able to give written informed consent
  • •11. Aged greater than 18 years
  • •12. No other acute or chronic medical or psychiatric conditions which might have a significant influence on choice of the appropriate location of the patient to receive treatment
  • •13. Easter Cooperative Oncology Group (ECOG) performance status less than 2; if ECOG PS 2, there must be a second individual living in the home who functions as a carer
  • •14. Either sex, lower age limit of 18 years

排除标准

  • •1. Any patient receiving an unlicensed cancer drug treatment as part of a clinical trial, where the drug is defined as an investigational medical product (IMP), unless the trial itself has received ethics and research and development approval to be conducted in designated community settings used in the Outreach Trial
  • •2. Patients with language barriers or communication difficulties whose safety might potentially be compromised by entry into this trial (in the opinion of the Investigator)
  • •3. Any patient, where, in the opinion of the investigator, entry into this trial would give cause for concern regarding patient safety

研究者

相似试验